GENOMED SPÓŁKA AKCYJNA
CopyKey data
Status
KRS number
REGON
NIP/VAT code
VAT registration date
VAT status
Bankruptcy proceedings
GENOMED SPÓŁKA AKCYJNA
Contacts
Registered address
Website
WWW.GENOMED.PLA
HighestReliability
Incorporation date
30/12/2010Share capital
132,130.10 PLNRepresentatives
5Representatives rights
DO REPREZENTOWANIA SPÓŁKI UPRAWNIENI SĄ DWAJ CZŁONKOWIE ZARZĄDU DZIAŁAJĄCY ŁĄCZNIE ALBO CZŁONEK ZARZĄDU DZIAŁAJĄCY Z PROKURENTEMRepresentatives
Business linkages
Compliance screening
Check whether your partner is listed in sanctions or PEP registers, or linked to negative public information or law enforcement reports. Ensure business safety and compliance.People
Representatives
Person | Title |
|---|---|
Anna Maria Boguszewska Chachulska | Chairman of the management board |
Andrzej Henryk Pałucha | Member of the management board |
Anna Maria Piotrowska Mietelska | Member of the management board |
Iwona Wach | Member of the management board |
Marek Zagulski | Member of the management board |
Persons with Significant Control
Financial ratios
Net Profit (zł)
1,105,239Net Profit (zł)
1,105,239Financial report (Okredo)
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (zł) |
| Profit before tax (zł) |
| Net Profit (zł) |
| Working capital requirement (%) |
| Liquidity ratio |
| Net profitability (%) |
| Equity (zł) |
| Current liabilities (zł) |
| Non current liabilities (zł) |
| Non-current Assets (zł) |
| 2022 |
|---|
| 20,459,465 |
| 368,892 |
| 337,957 |
| 0.30 |
| 6.97 |
| 1.65 |
| 9,134,687 |
| 1,042,017 |
| 21,830 |
| 1,704,176 |
| 2023 |
|---|
| 22,481,677 |
| 1,051,778 |
| 926,247 |
| 0.34 |
| 5.50 |
| 4.12 |
| 10,060,934 |
| 1,711,989 |
| 6,363 |
| 1,289,446 |
| 2024 |
|---|
| 23,006,873 |
| 1,213,081 |
| 1,105,239 |
| 0.34 |
| 7.01 |
| 4.80 |
| 10,717,673 |
| 1,311,848 |
| 0 |
| - |
| 2024 |
|---|
| 23,006,873 |
| 1,213,081 |
| 1,105,239 |
| 0.34 |
| 7.01 |
| 4.80 |
| 10,717,673 |
| 1,311,848 |
| 0 |
| - |
Turnover (zł)
2024
Turnover (zł)
23,006,873 zł2 % *
Profit before tax (zł)
1,213,081 zł15 % *
Net Profit (zł)
1,105,239 zł19 % *
Working capital requirement (%)
0.34 0.00 % *
Liquidity ratio
7.01 27.45 % *
Net profitability (%)
4.80 %16.50 % *
Equity (zł)
10,717,673 zł7 % *
Current liabilities (zł)
1,311,848 zł-23 % *
Non current liabilities (zł)
0 zł-100 % *
Non-current Assets (zł)
-Credit history
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Order reportCreditor/Data source | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Documents
GENOMED SPÓŁKA AKCYJNA Documents
Date | Description |
|---|---|
02/07/2025 | OD 01.01.2024 DO 31.12.2024 |
02/07/2024 | OD 01.01.2023 DO 31.12.2023 |
07/07/2023 | OD 01.01.2022 DO 31.12.2022 |
04/07/2022 | OD 01.01.2021 DO 31.12.2021 |
02/07/2021 | OD 01.01.2020 DO 31.12.2020 |
Frequently Asked Questions
What is the current status of GENOMED SPÓŁKA AKCYJNA?
GENOMED SPÓŁKA AKCYJNA is currently Active. It was registered on 30/12/2010.
Where is GENOMED SPÓŁKA AKCYJNA located?
GENOMED SPÓŁKA AKCYJNA is registered at PONCZOWA 12, 02-971, WARSZAWA, POLSKA.
What does GENOMED SPÓŁKA AKCYJNA do?
GENOMED SPÓŁKA AKCYJNA operates in the Research and experimental development on biotechnology (72.11.Z - PKD 2007) sector.
What is the annual turnover of GENOMED SPÓŁKA AKCYJNA?
GENOMED SPÓŁKA AKCYJNA reported a turnover of 23,006,873 PLN in 2024.
What is the net profit of GENOMED SPÓŁKA AKCYJNA?
GENOMED SPÓŁKA AKCYJNA reported a net profit of 1,105,239 PLN in 2024.
Is GENOMED SPÓŁKA AKCYJNA a reliable company?
GENOMED SPÓŁKA AKCYJNA Pre-Score* rating is A, which indicates the highest level of reliability.
* The credit score is calculated based on financial data, payment history, and other risk indicators.Does GENOMED SPÓŁKA AKCYJNA have any unpaid debts?
GENOMED SPÓŁKA AKCYJNA has no recorded unpaid debts.